Fig. 6

Akerberg et al., 2022 - RBPMS2 Is a Myocardial-Enriched Splicing Regulator Required for Cardiac Function
Other Figures
All Figure Page
Back to All Figure Page
Fig. 6

Conservation of RBPMS2 (RNA-binding protein with multiple splicing [variants] 2)-regulated splicing events in zebrafish and human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs). A, Volcano plot showing the inclusion (Inc) level differences (InclevelCTRL–InclevelΔRBPMS2) and false discovery rates (FDRs) for differential alternative splicing events (ASEs) between wild-type control (CTRL; n=4 from independent differentiations) and ΔRBPMS2 (n=5) filtered by 0 uncalled replicates, FDR<0.05 (capped at 10-16), and |Incleveldifference|>0.1. B, Pie chart showing the proportions of differential ASEs in each category in ΔRBPMS2 hiPSC-CMs. Also shown are the percentages of exons in the skipped exon category that are differentially included or excluded in ΔRBPMS2 hiPSC-CMs. C, Schematic diagram (left, top), table (left, bottom), and stacked bar chart (right) showing gene- and exon-level comparisons of the splicing defects in RBPMS2-deficient zebrafish (GRCz11[genome reference consortium zebrafish build 11]) and hiPSC-CMs (Hg38 [genome reference consortium human build 38]) made by ExOrthist software using the zebrafish ASEs as the query group. Of the 166 differential ASEs, 6 were in low-confidence orthologs (not shown in C, right). A3SS indicates alternative 3′ splice site; A5SS, alternative 5′ splice site; MXE, mutually exclusive exon; RI, retained intron; rMATS, replicate multivariate analysis of transcript splicing; and SE, skipped exon.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Circ. Res.